Rajesh Exports Ltd. is facing heightened regulatory scrutiny after the Securities and Exchange Board of India (SEBI) issued an interim ex-parte order against the company and its Chairman and Managing Director, Rajesh Mehta. The regulator cited prima facie findings of financial misrepresentation, alleged fund-routing through unverified entities, and lack of cooperation with investigators during an ongoing probe.

As part of the interim measures, SEBI has barred Rajesh Mehta from dealing in the company's securities and directed Rajesh Exports to fully cooperate with investigating officers and forensic auditors examining its books and records.

The regulator's action follows concerns that the company may have materially overstated revenues over several years and failed to provide adequate information during the investigation.

The regulatory action has also brought the company's institutional ownership into focus. According to the latest available shareholding data, Life Insurance Corporation of India (LIC) holds more than 10% of Rajesh Exports, making it one of the company's largest institutional investors. Foreign institutional investors collectively own nearly 14% of the company, reflecting meaningful institutional exposure despite the ongoing governance concerns.

SEBI's findings have raised concerns among investors regarding corporate governance standards, financial transparency, and the reliability of the company's reported financial performance. Market participants are expected to closely monitor the outcome of the forensic review and any further regulatory action that may emerge from the investigation.

The case is likely to remain a key focus for investors given the company's significant institutional shareholding and its position in India's jewellery and gold refining industry. Any adverse findings from the ongoing investigation could have implications for investor sentiment and the company's market standing.